Evaluation of mTOR, NFκB and BCL-2 Inhibitor Activity In Vitro in Karpas 1106P, a Primary Mediastinal B-Cell Lymphoma Cell Line
<b>Introduction</b>: PMBCL is an aggressive type of lymphoma characterized by high heterogeneity in clinical, molecular, and genetic features. In PMBCL, disturbances in the NFkB pathway and deregulation of BCL-2 and mTOR family proteins are observed, which may contribute to impaired apoptosis. There...
Spremljeno u:
| Glavni autori: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2026-03-01
|
| Serija: | Hematology Reports |
| Teme: | |
| Online pristup: | https://www.mdpi.com/2038-8330/18/2/25 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|